These findings align with the conclusions drawn by Ke-Liang Li et al., showing decreased levels of IL-2, TNF alpha and INF-gamma in both human in vitro and mice in vivo acute-GVHD models after treatment with MSC-derived sEVs [25]. This evidence concerns the gene TNF and graft versus host disease.